Effects of inhaled indacaterol and inhaled tiotropium on impulse oscillation system (IOS)-assessed measures of peripheral airway resistande and reactance in patients with COPD
Not Applicable
- Conditions
- chronic obstructive pulmonary disease (COPD)
- Registration Number
- JPRN-UMIN000010262
- Lead Sponsor
- Tokyo Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient of the symptom that bronchial asthma is main. 2. Patient who have complications as heart diseases 3. Patient who uses home oxygen therapy. 4. Patients with a history of hypersensitivity to Tiotropium or Indacaterol. 5. Patient who was considered ineligible to use bata2 agonist in a patient complicated with hyperthyroidism, hypertension, heart disease and diabetes mellitus. 6. Woman who are pregnant or breast feeding, and woman of childbearing potential. 7. Patient who was considered ineligible by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method